Literature DB >> 4084256

Effects of haloperidol and low dose clozapine on the acetylcholine turnover rate in rat forebrain structures.

R Bluth, R Langnickel.   

Abstract

The contents of acetylcholine and choline as well as the acetylcholine turnover rates were measured in olfactory tubercle, nucleus accumbens and striatum of rats receiving haloperidol and low dose clozapine intraperitoneally. Both haloperidol (1 mg/kg) and clozapine (1.25 mg/kg) led to an increase in the acetylcholine turnover in the mesolimbic nucleus accumbens and olfactory tubercle. However, the acetylcholine turnover in the striatum was affected differently by each antipsychotic. Whereas haloperidol elicited an increase in the acetylcholine turnover, the atypical neuroleptic clozapine failed to change this parameter in striatum. It can be concluded that haloperidol increases the acetylcholine turnover in both striatum and mesolimbic areas by blocking dopamine receptors localized at cholinergic interneurons. In contrast, it may be speculated that a low dose of clozapine appears to modulate the cholinergic activity by a preferential serotonin antagonist action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4084256

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  3 in total

Review 1.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine.

Authors:  A R Cools; E P Prinssen; B A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

3.  Effects of Tianeptine on Adult Rats Following Prenatal Stress.

Authors:  Hwayoung Lee; Hyung-Ki Kim; Jun-Tack Kwon; Young Ock Kim; Jonghoon Seo; Sanghyun Lee; Ik-Hyun Cho; Hak-Jae Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-05-31       Impact factor: 2.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.